Paroxetine Extended-Release Tablets USP, 12.5 mg, 30 count bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland, 21202, Manufactured by: Lupin Limited, Pithampur (M.P.) 454 775, India, NDC: 68180-647-06
Published July 19, 2017 · Recall initiated: June 22, 2017
Summary
FDA records drug Class III recall D-0974-2017, published July 19, 2017 and initiated June 22, 2017. Recalling firm: Lupin Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 12480 bottles; Lot: Lots: H605712, H605711, H605710, EXP November 2018; H702255, H702202 EXP March 2019. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications: out of specification observed in dissolution testing at 3 month long term stability study.
What to do
Voluntary: Firm initiated · Letter
Get an email if PAROXETINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- PAROXETINE
- Manufacturer
- Lupin Pharmaceuticals Inc.
- Distributor
- Nationwide in the USA
- Lot
- Lots: H605712, H605711, H605710, EXP November 2018; H702255, H702202 EXP March 2019
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAPAROXETINE tablets, USP, 10 mg, Packaged as a) 30-count bottle, NDC 60429-734-30; b) 90-count bottle NDCDecember 6, 2023
- FDAParoxetine Hydrochloride Tablets USP, RX only, 30 mg, a)30-count bottle, NDC#: 60505-0084-1, b)100-countDecember 6, 2023
- FDAParoxetine Hydrochloride Tablets USP, RX only, 10 mg a) 30-count bottle, NDC#: 60505-0097-1; b) 100-countDecember 6, 2023
- FDAPAROXETINE tablets, USP, 40 mg, Packaged as a) 30-count bottle, NDC 60429-737-30; b) 90-count bottle NDCDecember 6, 2023
- FDA0.9% Sodium Chloride Injection, USP, 100 mL VIAFLEX Container, Rx Only, Baxter Healthcare Corporation,July 19, 2017
- FDACVS Health Baby Eczema Moisturizing Cream(colloidal oatmeal 1.0%), Net Wt. 7.3 oz (207g) tubes, OTC,July 19, 2017
Questions about this recall
Was Paroxetine Extended-Release Tablets USP, 12.5 mg, 30 count bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland, 21202, Manufactured by: Lupin Limited, Pithampur (M.P.) 454 775, India, NDC: 68180-647-06 recalled?
Yes. FDA published recall D-0974-2017 on July 19, 2017. Reported hazard: Failed Dissolution Specifications: out of specification observed in dissolution testing at 3 month long term stability study.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: PAROXETINE.